DOCSLIB.ORG

Appendix A: Rating Scales

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Appendix A: Rating Scales Appendix A: Rating scales Compiled by Waguih William IsHak, MD, FAPA © Springer International Publishing AG 2017 599 W.W. IsHak (ed.), The Textbook of Clinical Sexual Medicine, DOI 10.1007/978-3-319-52539-6 600 Appendix A: Rating scales Summary table of selected scales and questionnaires Level Questionnaire Target population Items Domains Published cutoff scores of evidence Selected sexual functioning scales and questionnaires Female Sexual Function Women—heterosexual 19 and 6 Sexual function, Available for pre- and A-1 Index (FSFI) [1] and homosexual including desire, postmenopausal women arousal, lubrication, and women with medical orgasm, satisfaction, and sexual disorders and pain Sexual Functioning Women—heterosexual 28 Desire, arousal, Available B-3 Questionnaire (SFQ) [2, 3] and sexually active during orgasm, pain, past 4 weeks enjoyment, and partner relationship Female Sexual Distress Women—pre- and 13 and 1 Distress about sexual Available A-1 Scale–Revised (FSDS-R) [4] postmenopausal life dissatisfied with their sexual function Sexual Interest and Desire Women—premenopausal 15 Hypoactive sexual Available on women B-2 Inventory (SIDI) [5–7] with low desire desire disorder with no sexual desire disorder International Index of Men from community and 10 and 5 Erectile function, Available A-1 Erectile Function (IIEF) medical populations orgasmic function, [8–10] sexual desire, intercourse satisfaction, and overall satisfaction Male Sexual Health Men—middle age or 25 and 4 Ejaculation, erection, Available B-2 Questionnaire (MSHQ) [11] aging with urogenital and sexual satisfaction symptoms of LUTS and sexual dysfunction Premature Ejaculation Men 4 Satisfaction with sexual Not available B-2 Profile (PEP) [12] intercourse, control over ejaculation, ejaculation-related distress, and interpersonal difficulty Index of Premature Men Control, sexual Available B-2 Ejaculation (IPE) [13] satisfaction, and distress Sexual function questionnaires for specific patient populations PROMIS Sexual Function Patients with cancer 79 Interest in sexual Available A-1 and Satisfaction (SexFS) activity, lubrication, [14, 15] vaginal discomfort, erectile function, global satisfaction with sex life, orgasm, anal discomfort, therapeutic aids, sexual activities, interfering factors, and screener questions European Organization for Patients with cancer 30 Quality of life and Available A-2 Research and Treatment of sexual function Cancer (EORTC) QLQ-C30 [16]; also disease-­specific modules such as prostate cancer [17] Multiple Sclerosis Intimacy Patients with MS 19 and 15 Primary, secondary, Not available B-1 and Sexuality Questionnaire and tertiary sexual (MSISQ-­19) [18] dysfunction (continued) Appendix A: Rating scales 601 (continued) Level Questionnaire Target population Items Domains Published cutoff scores of evidence Peyronie’s disease [19–21] Men—Peyronie’s disease 15 Psychological and Not available A-1 physical symptoms, Peyronie’s symptom bother, and penile pain Pelvic Organ Prolapse/ Women—pelvic organ 31 and 12 Behavioral and Not available B-2 Urinary Incontinence prolapse, urinary emotive, physical, and Sexual Questionnaire incontinence, fecal partner related (PISQ) [22] incontinence Spinal Cord Injury Patients with spinal cord 16 Secondary conditions Not available C-3 Secondary Conditions injury and dissatisfaction with Scale (SCI-SCS) [23] sexual function Antipsychotics and Sexual Patients under 11 + 3 for men Sexual functioning Not available C-1 Functioning Questionnaire antipsychotic medication and 5 for (ASFQ) [24, 25] women, semistructured interview Female Genital Self-Image Female or male genital 4 women, 5 Feelings and beliefs Not available A-1 Scale (FGSIS) and Male self-image on sexual male about own genitals Genital Self-Image Scale function and behavior (MGSIS) [26, 27] Penile Dysmorphic Men 9 Penile dysmorphic Available B-2 Disorder Scale [28] disorder Treatment outcome and sexual quality-of-life scales Erectile Dysfunction Men with ED and their 29 Treatment satisfaction Not available A-1 Inventory for Treatment partners (men) and partner and Satisfaction (EDITS) satisfaction (women) [29–31] Treatment Satisfaction Men with ED and their 40 (all modules Satisfaction with Not available A-2 Scale [32] partner together) medication, ease with erection, satisfaction with erectile function, pleasure from sexual activity, satisfaction with orgasm, and either sexual confidence (for patients) or confidence in completion (for partners) Self-Esteem and Men with ED 14 Self-esteem, Not available A-1 Relationship Scale confidence, and (SEAR) [33] relationships Psychological and Men >65 year old 23 Sexual confidence, Not available B-1 Interpersonal Relationship spontaneity, time Scale (PAIRS) [34] concerns, relative to treatment Sexual Quality of Life for Men with ED or PE and 11 and 18 Sexual confidence, Not available C-2 men (SQOL-M) and women with HSDD or emotional well-­being, women (SQOL-F) [35] FSAD and relationship issues ED erectile dysfunction, FSAD female sexual arousal disorder, SE, Lonnee-Hoffmann RA, Dennerstein L, Rosen RC. Diagnosing HSDD hypoactive sexual desire disorder, LUTS lower urinary Sexual Dysfunction in Men and Women: Sexual History Taking tract symptoms, MS multiple sclerosis, PE premature ejaculation. and the Role of Symptom Scales and Questionnaires. J Sex Med. [Reprinted from Hatzichristou D, Kirana PS, Banner L, Althof 2016;13(8): 1166–82 with permission from Elsevier] 602 Appendix A: Rating scales NIH PROMIS Measures © 2008–2017 PROMIS Health Organization and PROMIS Cooperative Group. Reprinted with permission Appendix A: Rating scales 603 © 2008–2017 PROMIS Health Organization and PROMIS Cooperative Group. Reprinted with permission 604 Appendix A: Rating scales © 2008–2017 PROMIS Health Organization and PROMIS Cooperative Group. Reprinted with permission Appendix A: Rating scales 605 © 2008–2017 PROMIS Health Organization and PROMIS Cooperative Group. Reprinted with permission References 1. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index 15. Flynn KE, Reeve BB, Lin L, et al. Construct validity of the (FSFI): a multidimensional self-report instrument for the assessment of PROMIS(R) sexual function and satisfaction measures in patients female sexual function. J Sex Marital Ther. 2000;26:191–208. with cancer. Health Qual Life Outcomes. 2013;11:40. 2. Quirk FH, Heiman JR, Rosen RC, et al. Development of a sexual 16. Jeffery DD, Barbera L, Andersen BL, et al. Self-reported sexual function questionnaire for clinical trials of female sexual dysfunc- function measures administered to female cancer patients: a system- tion. J Womens Health Gend Based Med. 2002;11:277–89. atic review, 2008e2014. J Psychosoc Oncol. 2015;33:433–66. 3. Quirk F, Haughie S, Symonds T. The use of the sexual function 17. O’Leary E, Drummond FJ, Gavin A, et al. Psychometric evaluation questionnaire as a screening tool for women with sexual dysfunc- of the EORTC QLQ-PR25 questionnaire in assessing health-related tion. J Sex Med. 2005;2:469–77. quality of life in prostate cancer survivors: a curate’s egg. Qual Life 4. Derogatis LR, Rosen R, Leiblum S, et al. The Female Sexual Res. 2015;24:2219–30. Distress Scale (FSDS): initial validation of a standardized scale for 18. Sanders A, Foley F, Larocca N, et al. The Multiple Sclerosis assessment of sexually related personal distress in women. J Sex Intimacy and Sexuality Questionnaire-19 (MSISQ-19). Sex Disabil. Marital Ther. 2002;28:317–30. 2000;18:3–26. 5. Sills T, Wunderlich G, Pyke R, et al. The Sexual Interest and Desire 19. Hellstrom WJ, Feldman R, Rosen RC, et al. Bother and distress Inventory-Female (SIDI-F): item response analyses of data from associated with Peyronie’s disease: validation of the Peyronie’s dis- women diagnosed with hypoactive sexual desire disorder. J Sex ease questionnaire. J Urol. 2013;190:627–34. Med. 2005;2:801–18. 20. Coyne KS, Currie BM, Thompson CL, et al. Responsiveness of the 6. Clayton AH, Segraves RT, Leiblum S, et al. Reliability and validity Peyronie’s Disease Questionnaire (PDQ). J Sex Med. of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale 2015;12:1072–9. designed to measure severity of female hypoactive sexual desire dis- 21. Coyne KS, Currie BM, Thompson CL, et al. The test-retest reliability order. J Sex Marital Ther. 2006;32:115–35. of the Peyronie’s Disease Questionnaire. J Sex Med. 2015;12:543–8. 7. Clayton AH, Goldmeier D, Nappi RE, et al. Validation of the sexual 22. Rogers RG, Kammerer-Doak D, Villarreal A, et al. A new instru- interest and desire inventory-female in hypoactive sexual desire dis- ment to measure sexual function in women with urinary inconti- order. J Sex Med. 2010;7:3918–28. nence or pelvic organ prolapse. Am J Obstet Gynecol. 8. Rosen RC, Riley A, Wagner G, et al. The International Index of 2001;184:552–8. Erectile Function (IIEF): a multidimensional scale for assessment of 23. Kalpakjian CZ, Scelza WM, Forchheimer MB, et al. Preliminary erectile dysfunction. Urology. 1997;49:822–30. reliability and validity of a Spinal Cord Injury Secondary Conditions 9. Rosen RC, Cappelleri JC, Gendrano III N. The International Index Scale. J Spinal Cord Med. 2007;30:131–9. of Erectile Function (IIEF): a state-of-the-science review. Int 24. De Boer MK, Castelein S, Bous J, et al. The Antipsychotics and J Impot Res. 2002;14:226–44. Sexual Functioning Questionnaire (ASFQ): preliminary evidence 10. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evalu- for reliability and validity. Schizophr Res. 2013;150:410–5. ation of an abridged, 5-item version of the International Index of 25. De Boer MK, Castelein S, Wiersma D, et al. A systematic review of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunc- instruments to measure sexual functioning in patients using antipsy- tion. Int J Impot Res. 1999;11:319–26. chotics. J Sex Res. 2014;51:383–9. 11. Rosen RC, Catania J, Pollack L, et al. Male Sexual Health 26. Herbenick D, Reece M. Development and validation of the female Questionnaire (MSHQ): scale development and psychometric vali- genital self-image scale. J Sex Med.
Load more

Recommended publications
  • Sexual Disorders and Gender Identity Disorder
    CHAPTER :13 Sexual Disorders and Gender Identity Disorder TOPIC OVERVIEW Sexual Dysfunctions Disorders of Desire Disorders of Excitement Disorders of Orgasm Disorders of Sexual Pain Treatments for Sexual Dysfunctions What are the General Features of Sex Therapy? What Techniques Are Applied to Particular Dysfunctions? What Are the Current Trends in Sex Therapy? Paraphilias Fetishism Transvestic Fetishism Exhibitionism Voyeurism Frotteurism Pedophilia Sexual Masochism Sexual Sadism A Word of Caution Gender Identity Disorder Putting It Together: A Private Topic Draws Public Attention 177 178 CHAPTER 13 LECTURE OUTLINE I. SEXUAL DISORDERS AND GENDER-IDENTITY DISORDER A. Sexual behavior is a major focus of both our private thoughts and public discussions B. Experts recognize two general categories of sexual disorders: 1. Sexual dysfunctions—problems with sexual responses 2. Paraphilias—repeated and intense sexual urges and fantasies to socially inappropri- ate objects or situations C. In addition to the sexual disorders, DSM includes a diagnosis called gender identity dis- order, a sex-related pattern in which people feel that they have been assigned to the wrong sex D. Relatively little is known about racial and other cultural differences in sexuality 1. Sex therapists and sex researchers have only recently begun to attend systematically to the importance of culture and race II. SEXUAL DYSFUNCTIONS A. Sexual dysfunctions are disorders in which people cannot respond normally in key areas of sexual functioning 1. As many as 31 percent of men and 43 percent of women in the United States suffer from such a dysfunction during their lives 2. Sexual dysfunctions typically are very distressing and often lead to sexual frustra- tion, guilt, loss of self-esteem, and interpersonal problems 3.
    [Show full text]
  • I the NATURE of SCHIZOTYPY AMONG
    THE NATURE OF SCHIZOTYPY AMONG MULTIGENERATIONAL MULTIPLEX SCHIZOPHRENIA FAMILIES by Sarah Irene Tarbox, PhD B.A. Psychology, Brandeis University, 1997 M.S. Psychology, University of Pittsburgh, 2005 Submitted to the Graduate Faculty of Arts and Sciences in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2010 i UNIVERSITY OF PITTSBURGH Faculty of Arts and Sciences This dissertation was presented by Sarah I. Tarbox It was defended on September 8, 2009 and approved by JeeWon Cheong, PhD, Department of Psychology, University of Pittsburgh Daniel Shaw, PhD, Department of Psychology, University of Pittsburgh Vishwajit Nimgaonkar, M.D., PhD, Department of Psychiatry, University of Pittsburgh Laura Almasy, PhD, Department of Genetics, Southwest Foundation for Biomedical Research Dissertation Advisor and Chair: Michael Pogue-Geile, PhD, Department of Psychology, University of Pittsburgh ii Copyright © by Sarah I. Tarbox 2010 iii Michael F. Pogue-Geile, Ph.D. THE NATURE OF SCHIZOTYPY AMONG MULTIGENERATIONAL MULTIPLEX SCHIZOPHRENIA FAMILIES Sarah I. Tarbox, PhD University of Pittsburgh, 2010 Identification of endophenotypes (I. I. Gottesman & Gould, 2003; I. I. Gottesman & Shields, 1972) that correlate with familial liability to schizophrenia and are maximally sensitive to a homogeneous subset of risk genes is an important strategy for detecting genes that affect schizophrenia risk. Symptoms of schizotypy may correlate with familial liability to schizophrenia; however, there are critical limitations of the current literature concerning this association. The present study examined the genetic architecture and genetic association between schizotypy and genetic liability to schizophrenia among multigenerational, multiplex schizophrenia families. Genetic schizotypy factors were identified that significantly correlated with genetic liability to schizophrenia, although some relations were unexpected in direction.
    [Show full text]
  • The Social Defeat Animal Model of Depression Shows
    Neuroscience 218 (2012) 138–153 THE SOCIAL DEFEAT ANIMAL MODEL OF DEPRESSION SHOWS DIMINISHED LEVELS OF OREXIN IN MESOCORTICAL REGIONS OF THE DOPAMINE SYSTEM, AND OF DYNORPHIN AND OREXIN IN THE HYPOTHALAMUS C. NOCJAR, a,b* J. ZHANG, c P. FENG a,c AND INTRODUCTION J. PANKSEPP d A reduced ability to experience pleasure, termed anhedo- a Department of Psychiatry, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA nia, is a hallmark symptom of depression and is expressed in rodent models of the illness. Various studies suggest that b Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA a dynorphin and orexin interactive dysfunction between the hypothalamus and the dopamine reward system might c Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Case Western Reserve University, exist in depression; and perhaps cause anhedonia symp- Cleveland, OH, USA toms. Dynorphin and orexin modulate each other’s function d Department of Veterinary and Comparative Anatomy, (Eriksson et al., 2004; Li and van den Pol, 2006) as well as Pharmacology and Physiology, College of Veterinary brain reward mechanisms; though dynorphin typically Medicine, Washington State University, Pullman, WA, USA inhibits and orexin stimulates neural activity (Shippenberg, 2009; Aston-Jones et al., 2010). Dynorphin is also co-expressed in nearly all orexin neurons, which are exclu- Abstract—Anhedonia is a core symptom of clinical depres- sively located in dorsomedial and lateral regions of the sion. Two brain neuropeptides that have been implicated in anhedonia symptomology in preclinical depression mod- hypothalamus (Chou et al., 2001). Importantly, hedonic els are dynorphin and orexin; which are concentrated along behaviors that are commonly diminished in depressed lateral hypothalamic dopamine reward pathways.
    [Show full text]
  • Effects of Expressive Writing on Sexual Dysfunction, Depression, and PTSD in Women with a History of Childhood Sexual Abuse: Results from a Randomized Clinical Trial
    2177 ORIGINAL RESEARCH—PSYCHOLOGY Effects of Expressive Writing on Sexual Dysfunction, Depression, and PTSD in Women with a History of Childhood Sexual Abuse: Results from a Randomized Clinical Trial Cindy M. Meston, PhD, Tierney A. Lorenz, MA, and Kyle R. Stephenson, MA Department of Psychology, University of Texas at Austin, Austin, TX, USA DOI: 10.1111/jsm.12247 ABSTRACT Introduction. Women with a history of childhood sexual abuse (CSA) have high rates of depression, posttraumatic stress disorder, and sexual problems in adulthood. Aim. We tested an expressive writing-based intervention for its effects on psychopathology, sexual function, satisfaction, and distress in women who have a history of CSA. Methods. Seventy women with CSA histories completed five 30-minute sessions of expressive writing, either with a trauma focus or a sexual schema focus. Main Outcome Measures. Validated self-report measures of psychopathology and sexual function were conducted at posttreatment: 2 weeks, 1 month, and 6 months. Results. Women in both writing interventions exhibited improved symptoms of depression and posttraumatic stress disorder (PTSD). Women who were instructed to write about the impact of the abuse on their sexual schema were significantly more likely to recover from sexual dysfunction. Conclusions. Expressive writing may improve depressive and PTSD symptoms in women with CSA histories. Sexual schema-focused expressive writing in particular appears to improve sexual problems, especially for depressed women with CSA histories. Both treatments are accessible, cost-effective, and acceptable to patients. Meston CM, Lorenz TA, and Stephenson KR. Effects of expressive writing on sexual dysfunction, depression, and PTSD in women with a history of childhood sexual abuse: Results from a randomized clinical trial.
    [Show full text]
  • Chapter 05- Mental, Behavioral and Neurodevelopmental Disorders
    Chapter 5 Mental, Behavioral and Neurodevelopmental disorders (F01-F99) Includes: disorders of psychological development Excludes2: symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99) This chapter contains the following blocks: F01-F09 Mental disorders due to known physiological conditions F10-F19 Mental and behavioral disorders due to psychoactive substance use F20-F29 Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders F30-F39 Mood [affective] disorders F40-F48 Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders F50-F59 Behavioral syndromes associated with physiological disturbances and physical factors F60-F69 Disorders of adult personality and behavior F70-F79 Intellectual disabilities F80-F89 Pervasive and specific developmental disorders F90-F98 Behavioral and emotional disorders with onset usually occurring in childhood and adolescence F99 Unspecified mental disorder Mental disorders due to known physiological conditions (F01-F09) Note: This block comprises a range of mental disorders grouped together on the basis of their having in common a demonstrable etiology in cerebral disease, brain injury, or other insult leading to cerebral dysfunction. The dysfunction may be primary, as in diseases, injuries, and insults that affect the brain directly and selectively; or secondary, as in systemic diseases and disorders that attack the brain only as one of the multiple organs or systems of the body that are involved. F01 Vascular dementia
    [Show full text]
  • Musical Anhedonia: a Review
    JOURNAL OF PSYCHOPATHOLOGY 2020;26:308-316 Review DOI: 10.36148/2284-0249-389 Musical anhedonia: a review Francesco Bernardini1, Laura Scarponi2, Luigi Attademo3, Philippe Hubain4, Gwenolé Loas4, Orrin Devinsky5 1 SPDC Pordenone, Department of Mental Health, AsFO Friuli Occidentale, Pordenone, Italy; 2 USC Psichiatria 1, Department of Mental Health, ASST Papa Giovanni XXIII, Bergamo, Italy; 3 SPDC Potenza, Department of Mental Health, ASP Basilicata, Potenza, Italy; 4 Erasme Hos- pital, Université Libre de Bruxelles (ULB), Bruxelles, Belgium; 5 NYU Comprehensive Epilepsy Center, Department of Neurology, New York University School of Medicine, New York, USA SUMMARY Objectives Anhedonia, or the inability or the loss of the capacity to experience pleasure, is a core feature of several psychiatric disorders. Different types of anhedonia have been described includ- ing social and physical anhedonia, appetitive or motivational anhedonia, consummatory and anticipatory anhedonia. Musical anhedonia is a rare condition where individuals derive no reward responses from musical experience. Methods We searched the PubMed electronic database for all articles with the search term “musical anhedonia”. Results A final set of 12 articles (six original research articles and six clinical case reports) comprised the set we reviewed. Conclusions Individuals with specific musical anhedonia show normal responses to other types of reward, Received: April 21, 2020 suggesting a specific deficit in musical reward pathways. Those individuals are not necessar- Accepted: June 8, 2020 ily affected by psychiatric conditions, have normal musical perception capacities, and normal recognition of emotions depicted in music. Individual differences in the tendency to derive Correspondence pleasure from music are associated with structural connections from auditory association Francesco Bernardini areas in the superior temporal gyrus to the anterior insula.
    [Show full text]
  • Unit 3 Problems Related to Sex
    UNIT 3 PROBLEMS RELATED TO SEX Structure 3.0 Introduction 3.1 Objectives 3.2 Sexuality 3.3 Problems Related to Sex and Sexual Dysfunction 3.3.1 Classification of Sexual Dysfunction 3.3.2 Epidemiology of Sexual Dysfunction 3.3.3 Etiology of Sexual Dysfunction 3.3.4 Common Sexual Problems and Dysfunctions: Clinical Picture 3.3.5 Sexual Dysfunction: Diagnostic Evaluation 3.3.6 Management of Sexual Dysfunction 3.4 Gender Identity Disorders (Gender dysphoria) 3.5 Paraphilias 3.6 Homosexuality 3.7 Let Us Sum Up 3.8 Answers to Self-Assessment Questions 3.9 Unit End Questions 3.10 References 3.11 Suggested Readings 3.0 INTRODUCTION Love and intimacy form the foundation of any relationship. The characteristics of an intimate relationship include an enduring behavioural interdependence, attachment and need fulfillment. Intimate relationships include friendships, dating and marital relationships and spiritual relationships. Intimacy does not necessarily mean sex. Every human interaction offers the possibility of love, “a strong feeling of deep affection”. Love is a total submission of will, the absolute dedication of the entire being to the beloved. Sternberg has described three components of love: intimacy, commitment and passion. Passionate love is marked by a strong sexual longing. ‘Sex’ (as commonly used in English language) refers to male or female based on biological characteristics. However ‘gender’ refers to public lived role as male or female; gender identity refers to the social identity of the individual. Gender identity (usually set before 18 months of age) in a child is irreversibly established before 3 years of age.
    [Show full text]
  • Important Interaction Between Urethral Taste Bud-Like Structures and Onuf's
    +Model ANDROL-280; No. of Pages 10 ARTICLE IN PRESS Revista Internacional de Andrología xxx (xxxx) xxx---xxx www.elsevier.es/andrologia ORIGINAL Important interaction between urethral taste bud-like structures and Onuf’s nucleus following spinal subarachnoid hemorrhage: A hypothesis for the mechanism of dysorgasmia a b,∗ c d Ozgur Caglar , Mehmet Dumlu Aydin , Nazan Aydin , Ali Ahiskalioglu , e f g Ayhan Kanat , Remzi Aslan , Arif Onder a Department of Pediatric Surgery, Medical Faculty of Ataturk University, Erzurum, Turkey b Department of Neurosurgery, Medical Faculty of Ataturk University, Erzurum, Turkey c Department of Psychology, Humanities and Social Sciences Faculty, Uskudar University, Istanbul, Turkey d Department of Anesthesiology, Medical Faculty of Ataturk University, Erzurum, Turkey e Department of Neurosurgery, Medical Faculty of RTE University, Rize, Turkey f Department of Pathology, Medical Faculty of Ataturk University, Erzurum, Turkey g Department of Neurosurgery, Medical Faculty of Inonu University, Malatya, Turkey Received 30 October 2019; accepted 26 May 2020 KEYWORDS Abstract Urethral taste buds; Background: We previously postulated that orgasmic sensation may occur through recently Subarachnoid discovered genital taste bud-like structures. The interaction between the pudendal nerve haemorrhage; and Onuf’s nucleus may be important for developing orgasmic information. The study aims Anorgasmia to investigate whether ischemic damage to Onuf’s nucleus-pudendal network following spinal subarachnoid hemorrhage (SAH) causes taste bud degeneration or not. Methods: The study was conducted on 22 fertile male rabbits who were divided into three 3 groups: control (GI; n = 5), SHAM (GII; n = 5) and study (GIII; n = 12). Isotonic solution, .7 cm , 3 for the SHAM, and .7 cm homologous blood was injected into spinal subarachnoid spaces at S2 level of the study group.
    [Show full text]
  • Sex Differences in Symptom Presentation of Schizotypal
    Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Psychology Dissertations Student Dissertations, Theses and Papers 2009 Sex Differences in Symptom Presentation of Schizotypal Personality Disorder in First-Degree Family Members of Individuals with Schizophrenia Alexandra Duncan-Ramos Philadelphia College of Osteopathic Medicine, [email protected] Follow this and additional works at: http://digitalcommons.pcom.edu/psychology_dissertations Part of the Clinical Psychology Commons Recommended Citation Duncan-Ramos, Alexandra, "Sex Differences in Symptom Presentation of Schizotypal Personality Disorder in First-Degree Family Members of Individuals with Schizophrenia" (2009). PCOM Psychology Dissertations. Paper 40. This Dissertation is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Psychology Dissertations by an authorized administrator of DigitalCommons@PCOM. For more information, please contact [email protected]. Philadelphia College of Osteopathic Medicine Department of Psychology SEX DIFFERENCES IN SYMPTOM PRESENTATION OF SCHIZOTYPAL PERSONALITY DISORDER IN FIRST-DEGREE FAMILY MEMBERS OF INDIVIDUALS WITH SCHIZOPHRENIA By Alexandra Duncan-Ramos, M.S., M.S. Submitted in Partial Fulfillment of the Requirements of the Degree of Doctor of Psychology July 2009 PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE DEPARTMENT OF PSYCHOLOGY Dissertation Approval This is to certify that the thesis presented to us by Alexandra Duncan-Ramos on the 23rd day of July, 2009 in partial fulfillment of the requirements for the degree of Doctor of Psychology, has been examined and is acceptable in both scholarship and literary quality. Committee Members' Signatures: Barbara Golden, Psy.D., ABPP, Chairperson Brad Rosenfield, Psy.D. Monica E. Calkins, Ph.D.
    [Show full text]
  • Sexual Dysfunctions in Women
    ANRV307-CP03-10 ARI 2 March 2007 13:46 Sexual Dysfunctions in Women Cindy M. Meston and Andrea Bradford Department of Psychology, University of Texas at Austin, Austin, Texas 78712; email: [email protected] Annu. Rev. Clin. Psychol. 2007. 3:233–56 Key Words First published online as a Review in women’s sexuality, orgasm, desire, arousal, sexual pain Advance on October 12, 2006 Access provided by University of Texas - Austin on 06/08/16. For personal use only. The Annual Review of Clinical Psychology is Abstract Annu. Rev. Clin. Psychol. 2007.3:233-256. Downloaded from www.annualreviews.org online at http://clinpsy.annualreviews.org In this article, we summarize the definition, etiology, assessment, and This article’s doi: treatment of sexual dysfunctions in women. Although the Diagnostic 10.1146/annurev.clinpsy.3.022806.091507 and Statistical Manual of Mental Disorders, fourth edition (DSM-IV- Copyright c 2007 by Annual Reviews. TR) is our guiding framework for classifying and defining women’s All rights reserved sexual dysfunctions, we draw special attention to recent discussion 1548-5943/07/0427-0233$20.00 in the literature criticizing the DSM-IV-TR diagnostic criteria and their underlying assumptions. Our review of clinical research on sexual dysfunction summarizes psychosocial and biomedical man- agement approaches, with a critical examination of the empirical support for commonly prescribed therapies and limitations of re- cent clinical trials. 233 ANRV307-CP03-10 ARI 2 March 2007 13:46 women with sexual problems that are not Contents clinically diagnosable, on the opposite end of the spectrum is the percentage of women in INTRODUCTION................
    [Show full text]
  • Tutorial Letter 202/1/2016 Abnormal Behaviour and Mental Health
    PYC3702/202/1/2016 Tutorial Letter 202/1/2016 Abnormal Behaviour and Mental Health PYC3702 Semester 1 Department of Psychology Feedback – Assignment 02 The Examination Assignment 03 – Module Evaluation Survey Bar code PYC3702 ABNORMAL BEHAVIOUR AND MENTAL HEALTH TUTORIAL LETTER 202/2016 CONTENTS PAGE 1 FEEDBACK ON ASSIGNMENT 02 2 2 THE EXAMINATION 22 3 ASSIGNMENT 03 – MODULE EVALUATION SURVEY 23 Dear Student This is the last tutorial letter you will receive from your PYC3702 lecturers. We trust that you have found this module interesting and that by now you not only have a thorough knowledge and understanding of abnormal behaviour, but will also play a proactive role in your community and will cooperate to prevent abnormal behaviour. The examination is almost upon us and we trust that this tutorial letter will help you with your final preparations for the examination. We wish you all the best for the examination and hope that your hard work will be rewarded with good marks. If you are still experiencing any problems, or if there is anything about the contents of the course that is not clear, we appeal to you to contact one of your lecturers without delay. 1. Feedback on Assignment 02 As stated in Tutorial Letter 101/3/2016, Assignment 02 is a second compulsory assignment that helped you to prepare for the examination. The following chapters should have been studied in the prescribed book and Tutorial Letter: Trauma- and Stress-Related Disorders (Chapter 6, p. 165; Tutorial Letter 502/3/2016, p.28) Somatic and Dissociative Disorders (Chapter 7, p.
    [Show full text]
  • DIGS-CG-2.Pdf
    DIGS Comparison Guide II DIAGNOSTIC INTERVIEW FOR GENETIC STUDIES (DIGS) Purpose of Document: This document is to serve as a harmonized product representing all content from Versions 3.0/B (Study 1), 3.0 GenRED I (Study 7), 3.01 MD GenRED II v1 (Study 52, 8/2005), 3.01 MD GenRED II v2 (Study 52, 4/2006), 3.0 Revised 7 (Study 42), 3.0/Anorexia Nervosa (Study 24), and 4.0/BP (Study 40). Please note: 3.0/Anorexia Nervosa (Study 24) is only present in sections A, B, E, F, G, H, O, N, X, and Y. There are minimal differences between 3.0 GenRED I (Study 7), 3.01MD GenRedII v1 (Study 52), and 3.01 GenREDII v2 (Study 52). These differences are noted with unqiue square designs, which are explained under the "color system" heading. There is a section at the end of this instrument with additional materials from these three versions that are not in the other versions. There is a seprerate harmonized document representing all content from Versions 1.0 (Study BP 0/Study SZ 0), 2.0 (Study BP 0, Study 1/Study SZ 0/Study 2), 2.1 MGS (Study 6), 2.2 MGS (Study 29), 3.0 (Study 22), and 4.0 (Study 22) of the DIGS. DIAGNOSTIC INTERVIEW FOR GENETIC STUDIES (DIGS) Document Information: This document is to be read as any other DIGS instrument. The sections are represented the same in this product as they are in each version, beginning with Section A and ending with Section AA (followed by a reference section and an appendix) .
    [Show full text]